uniQure NV Sustainability Reports
uniQure N.V. is a biotechnology company focused on the development and commercialization of innovative gene therapies. Its primary programs include treatments for hemophilia B, Huntington's disease, and other severe genetic disorders.
Sector: Manufacturing
Country: Netherlands
Exchange: Nasdaq
LEI: 724500RPCTZLFYJZ3S98
FIGI: BBG005SSJYG4
11 reports from 2013 to 2025
